Sun Pharmaceutical Industries Annual General Meeting
Sun Pharmaceutical Industries Ltd published voting results for a Postal Ballot. Shareholders approved the reclassification of three promoter group members to the public category.
ALFA Filings
Every announcement, straight from the exchange
Every Sun Pharmaceutical Industries annual general meeting announcement on NSE and BSE, newest first, each with its own page.
Time
6 announcements with these filters
Sun Pharmaceutical Industries Ltd published voting results for a Postal Ballot. Shareholders approved the reclassification of three promoter group members to the public category.
Sun Pharma seeks shareholder approval via postal ballot to reclassify three members of the 'Promoter Group' to the 'Public' category, effective upon requisite approval.
Sun Pharmaceutical Industries held its 34th Annual General Meeting, approving financial statements, director appointments, and a final dividend of Rs. 5 per share.
SUN PHARMA announces its 34th AGM on 31 Jul 2026 to adopt financials and declare ₹5/share dividend. Director reappointments and remuneration revisions are also on the agenda.
Sun Pharmaceutical Industries scheduled its 34th AGM for July 31, 2026. The company fixed July 7, 2026, as the record date for a ₹5 per share dividend.
Sun Pharmaceutical shareholders approved the appointment of Ms. Satyavati Berera as Independent Director via postal ballot. The five-year term is effective from May 08, 2026.